DNA damage in inflammation-related carcinogenesis and cancer stem cells

Shiho Ohnishi1, Ning Ma2, Raynoo Thanan3

  • 1Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka 513-8670, Mie, Japan.

Insights

Infection and inflammation cause DNA damage, leading to cancer. This study shows that 8-nitroguanine in stem cells is key to inflammation-related carcinogenesis, implicating infectious agents in various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Infection and chronic inflammation are recognized drivers of carcinogenesis.
  • Inflammatory conditions generate reactive oxygen and nitrogen species (ROS/RNS), causing oxidative and nitrative DNA damage.
  • This DNA damage, including 8-oxodG and 8-nitroguanine, can lead to mutations and promote inflammation-mediated cancers.

Purpose of the Study:

  • To investigate the role of infectious agents in carcinogenesis.
  • To examine the formation of 8-nitroguanine in inflammation-associated cancers.
  • To explore the involvement of stem cells in inflammation-related carcinogenesis.

Main Methods:

  • Analysis of DNA damage markers (8-nitroguanine) in patient cancer tissues.
  • Assessment of inducible nitric oxide synthase (iNOS) expression.
  • Identification of 8-nitroguanine in specific stem cell populations (Oct3/4+, CD133+).

Main Results:

  • Infectious agents like Schistosoma haematobium, Opisthorchis viverrini, HCV, HPV, EBV, and H. pylori are linked to specific cancers.
  • Strong formation of 8-nitroguanine was observed at cancer sites, correlated with iNOS expression.
  • 8-nitroguanine was detected in Oct3/4-positive stem cells in bladder cancer and Oct3/4/CD133-positive stem cells in cholangiocarcinoma.

Conclusions:

  • Oxidative and nitrative DNA damage in stem cells is a critical factor in inflammation-related carcinogenesis.
  • Specific infectious agents are significant risk factors for various human cancers.
  • Targeting DNA damage in stem cells may offer therapeutic strategies for inflammation-driven cancers.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
28.9K